On 26 January 2017 Actelion and Johnson & Johnson announced that they have entered into a definitive transaction agreement under which Johnson & Johnson will launch an all-cash tender offer in Switzerland to acquire all of the outstanding shares of Actelion.

Find all information and updates concering the propesed transcation on this page

Johnson & Johnson Prospectus

16 February 2017:

Johnson & Johnson published the prospectus for their tender offer for Actelion.

Annual Report 2016

14 February 2017:

Actelion published its Annual Report.

Pre-Announcement Tender Offer

26 January 2017:

Actelion and Johnson & Johnson entered into a definitive transaction agreement.

Contact

Investor Relations
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil
Switzerland
Contact
Tel.: +41 61 565 62 62
Fax: +41 61 565 65 07
Contact us online